Results 161 to 170 of about 1,102,054 (309)
Drug-Drug Interactions in Recently Approved Antibacterials: A Mini Review. [PDF]
Baccari I, Bergmann F, Zeitlinger M.
europepmc +1 more source
Pharmacogenetics of drug-drug interaction and drug-drug-gene interaction
Currently, most guidelines on drug-drug interaction (DDI) neither consider the potential effect of genetic polymorphism in the strength of the interaction nor do they account for the complex interaction caused by the combination of DDI and drug-gene interaction (DGI) where there are multiple biotransformation pathways, which is referred to as drug-drug-
Bahar, Muh Akbar +3 more
openaire +1 more source
The cytoskeleton‐mediated transport of mitochondria via tunnelling nanotubes restores respiration, increases ATP production, rescues cells from apoptosis, activates the AKT/mTOR signalling pathway, promotes cell migration and invasiveness, contributes to cancer progression and treatment resistance.
Stanislava Martínková, Jan Trnka
wiley +1 more source
Zhi-Yu Wang,1 Meng Chen,1 Ling-Ling Zhu,2 Lu-Shan Yu,3 Su Zeng,3 Mei-Xiang Xiang,4 Quan Zhou1 1Department of Pharmacy, 2VIP Care Ward, Division of Nursing, the Second Affiliated Hospital, School of Medicine, 3Department of Pharmaceutical Analysis and ...
Yu LS +6 more
core
Response to Tutorial Drug-Drug Interactions by EM Sellers. [PDF]
Das JL, Ajavon-Hartmann AT, Schmith VGD.
europepmc +1 more source
Natural products target the aging kidney in diabetic nephropathy by restoring the AMPK–SIRT1–Nrf2 axis, reducing oxidative stress, inflammation, fibrosis, and cellular senescence while enhancing mitochondrial biogenesis and antioxidant defenses.
Sherif Hamidu +8 more
wiley +1 more source
In dermatological practice, physicians are increasingly encountering patients with multimorbidity who are undergoing polypharmacy. This requires an understanding of the potential interactions between patients’ existing medications and the prescribed ...
Jarosław Woroń
core +1 more source
Role of metabolites in drug-drug interactions. [PDF]
Isoherranen N.
europepmc +1 more source
Aging Is a Key Driver for Adult Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a classical age‐related hematologic malignancy, and a key driver of AML is aging, which profoundly regulates intrinsic factors such as genomic instability, epigenetic reprogramming, and metabolic dysregulation, and alters bone marrow microenvironment.
Rong Yin, Haojian Zhang
wiley +1 more source

